#mrd — Friday, May 01, 2026 (1 items)
| 0 | 💬 0 |
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.
(nature.com)
|
Nature Medicine 2026-05-01 | #antibody #immunotherapy #multiple myeloma #mrd |